Logo image of SONX

SONENDO INC (SONX) Stock Fundamental Analysis

NYSE:SONX - US8354311073 - Common Stock

0.23 USD
-0.01 (-4.33%)
Last: 11/21/2023, 8:04:01 PM
Fundamental Rating

2

Overall SONX gets a fundamental rating of 2 out of 10. We evaluated SONX against 187 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of SONX have multiple concerns. While showing a medium growth rate, SONX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year SONX has reported negative net income.
SONX had a negative operating cash flow in the past year.
SONX Yearly Net Income VS EBIT VS OCF VS FCFSONX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 -20M -40M -60M

1.2 Ratios

SONX has a Return On Assets of -68.96%. This is in the lower half of the industry: SONX underperforms 77.83% of its industry peers.
SONX has a Return On Equity of -161.08%. This is in the lower half of the industry: SONX underperforms 76.35% of its industry peers.
Industry RankSector Rank
ROA -68.96%
ROE -161.08%
ROIC N/A
ROA(3y)-48.29%
ROA(5y)N/A
ROE(3y)-102.18%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SONX Yearly ROA, ROE, ROICSONX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 -50 -100 -150

1.3 Margins

SONX's Gross Margin of 26.06% is on the low side compared to the rest of the industry. SONX is outperformed by 75.37% of its industry peers.
In the last couple of years the Gross Margin of SONX has remained more or less at the same level.
SONX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.24%
GM growth 5YN/A
SONX Yearly Profit, Operating, Gross MarginsSONX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 0 -50 -100 -150

More info and screens

3

2. Health

2.1 Basic Checks

SONX does not have a ROIC to compare to the WACC, probably because it is not profitable.
SONX has more shares outstanding than it did 1 year ago.
SONX has a worse debt/assets ratio than last year.
SONX Yearly Shares OutstandingSONX Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 10M 20M 30M 40M
SONX Yearly Total Debt VS Total AssetsSONX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 20M 40M 60M 80M 100M

2.2 Solvency

SONX has an Altman-Z score of -7.33. This is a bad value and indicates that SONX is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -7.33, SONX is doing worse than 73.89% of the companies in the same industry.
SONX has a Debt/Equity ratio of 0.98. This is a neutral value indicating SONX is somewhat dependend on debt financing.
SONX has a Debt to Equity ratio of 0.98. This is in the lower half of the industry: SONX underperforms 78.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF N/A
Altman-Z -7.33
ROIC/WACCN/A
WACC11.71%
SONX Yearly LT Debt VS Equity VS FCFSONX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 0 50M -50M

2.3 Liquidity

A Current Ratio of 6.80 indicates that SONX has no problem at all paying its short term obligations.
SONX's Current ratio of 6.80 is fine compared to the rest of the industry. SONX outperforms 79.80% of its industry peers.
SONX has a Quick Ratio of 5.77. This indicates that SONX is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of SONX (5.77) is better than 78.33% of its industry peers.
Industry RankSector Rank
Current Ratio 6.8
Quick Ratio 5.77
SONX Yearly Current Assets VS Current LiabilitesSONX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 20M 40M 60M 80M 100M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 72.34% over the past year.
SONX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.92%.
Measured over the past years, SONX shows a small growth in Revenue. The Revenue has been growing by 6.25% on average per year.
EPS 1Y (TTM)72.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70.21%
Revenue 1Y (TTM)12.92%
Revenue growth 3Y6.25%
Revenue growth 5YN/A
Sales Q2Q%5.69%

3.2 Future

The Earnings Per Share is expected to grow by 21.40% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 18.20% on average over the next years. This is quite good.
EPS Next Y65.53%
EPS Next 2Y30.85%
EPS Next 3Y21.4%
EPS Next 5YN/A
Revenue Next Year8.44%
Revenue Next 2Y14.38%
Revenue Next 3Y18.2%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SONX Yearly Revenue VS EstimatesSONX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
SONX Yearly EPS VS EstimatesSONX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 -1 -2 -3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

SONX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year SONX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SONX Price Earnings VS Forward Price EarningsSONX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SONX Per share dataSONX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

A more expensive valuation may be justified as SONX's earnings are expected to grow with 21.40% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.85%
EPS Next 3Y21.4%

More info and screens

0

5. Dividend

5.1 Amount

SONX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SONENDO INC

NYSE:SONX (11/21/2023, 8:04:01 PM)

0.23

-0.01 (-4.33%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-08 2023-11-08/amc
Earnings (Next)03-09 2024-03-09/amc
Inst Owners11.63%
Inst Owner Change0%
Ins Owners24.26%
Ins Owner Change0%
Market Cap12.48M
Analysts80
Price Target1.75 (660.87%)
Short Float %0%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-13.05%
Min EPS beat(2)-26.29%
Max EPS beat(2)0.18%
EPS beat(4)2
Avg EPS beat(4)-1.71%
Min EPS beat(4)-26.29%
Max EPS beat(4)23.85%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.65%
Min Revenue beat(2)-3.82%
Max Revenue beat(2)-1.48%
Revenue beat(4)2
Avg Revenue beat(4)-1.04%
Min Revenue beat(4)-3.82%
Max Revenue beat(4)1.03%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-36.28%
PT rev (3m)-37.73%
EPS NQ rev (1m)-1.82%
EPS NQ rev (3m)-1.82%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.83%
Revenue NQ rev (1m)-4.58%
Revenue NQ rev (3m)-4.58%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-8.05%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.28
P/FCF N/A
P/OCF N/A
P/B 0.33
P/tB 0.44
EV/EBITDA N/A
EPS(TTM)-0.65
EYN/A
EPS(NY)-0.52
Fwd EYN/A
FCF(TTM)-0.96
FCFYN/A
OCF(TTM)-0.94
OCFYN/A
SpS0.82
BVpS0.7
TBVpS0.53
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -68.96%
ROE -161.08%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 26.06%
FCFM N/A
ROA(3y)-48.29%
ROA(5y)N/A
ROE(3y)-102.18%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.24%
GM growth 5YN/A
F-Score4
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 56.8%
Cap/Sales 2.64%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.8
Quick Ratio 5.77
Altman-Z -7.33
F-Score4
WACC11.71%
ROIC/WACCN/A
Cap/Depr(3y)67.61%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.38%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)72.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70.21%
EPS Next Y65.53%
EPS Next 2Y30.85%
EPS Next 3Y21.4%
EPS Next 5YN/A
Revenue 1Y (TTM)12.92%
Revenue growth 3Y6.25%
Revenue growth 5YN/A
Sales Q2Q%5.69%
Revenue Next Year8.44%
Revenue Next 2Y14.38%
Revenue Next 3Y18.2%
Revenue Next 5YN/A
EBIT growth 1Y-3.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year14.36%
EBIT Next 3Y15.86%
EBIT Next 5YN/A
FCF growth 1Y-23.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-25.63%
OCF growth 3YN/A
OCF growth 5YN/A